Cosmetic Surgery Products Market is expected to reach US$ 59.34 Bn. at a CAGR of 4.5 during the forecast period 2029.Cosmetics Surgery ProductsMarket Overview & Dynamics:
Cosmetic surgery is a unique discipline of medicine, which is focused on enhancing physical appearance through surgical and medical techniques. Cosmetic surgery can be performed on all areas of the head, neck, and body. Cosmetic surgery continues to grow in popularity, with xx million cosmetic procedures carried out in the United States in 2019, an increase of 3 percent on the previous year.Cosmetics Surgery Products Market Snapshot
Rise in the demand for minimally invasive surgical procedures is expected to boost the market growth. The demand for cosmetics surgeries using minimally invasive methods, like botulinum toxin and facial filler injections have increased dramatically over the past decade and which is anticipated to drive the market during the forecast period. Major demand for these procedures has been observed in the US for the past few years. The main benefit of cosmetic surgery is that it helps to align your natural appearance with your desired appearance, resulting in an improved version of yourself. It also sometimes benefits in enhancing physical health, for example, a rhinoplasty surgery, not only will enhance the look and shape of your nose but may also help with respiratory issues that you may have. Along with physical health, it also helps in improving the psychological health of an individual, which helps him socialize due to an improved state of mind regarding how you feel towards yourself. Another key advantage to cosmetic surgery is that it produces results that often last a long time or are permanent. Due to the higher demand for cosmetic surgeries, it has become easily accessible and many clinics have been set up. These key benefits for cosmetic surgeries contribute to the growth of the market. Other driving factors for the market also include rising disposable income, increasing social awareness, rising demand for these procedures in the entertainment industry, and an increase in the number of traumatic injuries requiring reconstructive changes. High cost of cosmetic surgeries may hamper the market growth. Expensive cosmetic surgeries become ‘not so easily accessible’ in many developing and middle-income economies. This proves as the main factor which may hamper the market growth. Many times, recovery time can be long about 2-3 weeks, which may restrain the market from growing. Also, no availability of reimbursement policies in developed nations slows down the growth rate. The report covers the detailed analysis of global Cosmetic Surgery Products industry with the classifications of the market. Analysis of past market dynamics from 2018 to 2022 is given in the report, which will help readers to benchmark the past trends with current market scenarios with the key players contribution in it. The report has profiled nineteen key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for future hot spot in APAC region.
To know about the Research Methodology :- Request Free Sample Report
Regional Insights:
North America is expected to hold a dominant share of xx% during forecast period. Owing to the rising number of people focusing on the external aesthetics, rising geriatric population pool, and the improvements that is being done in cosmetic procedures, North America is expected to dominate the global market by holding a significant share of xx%. Rising number of trauma cases and accidents, increasing awareness, advancements in R&D for improving and addition of the new advanced techniques and new product launches are few key factors responsible to raise the bar of the market in the region. Asia Pacific is expected as the fastest growing region during forecast period at a CAGR of xx%. The Asia Pacific will command the global market owing to the drivers like improved medical infrastructure, presence of large target population, for example, rising demand for these procedures in the entertainment industry, adaptation of minimally invasive techniques, increased awareness, development of innovative and cost-effective solutions, improved standard of living, and rise in disposable income. The market is anticipated to experience fast development in demand for Cosmetic Surgery Products in emerging countries such as Japan, China, Brazil, India, Indonesia, and South Korea over the forecast period.Segment Analysis:
The global Cosmetic Surgery Products Market is segmented based on types, applications, and end-users. On the basis of type, it is sub-segmented into Injectables, implants, equipment, and others. The implants segment accounted for the major share of the market, with almost xx% of the total market in 2022, and is expected to show steady growth over the next five years. The implants segment consists of surgeries such as breast implants, facial implants, nose implants, and ear implants. Both invasive and non-invasive surgical procedures are used to embed cosmetic implants in an individual’s body. Patients are opting to replace their damaged/missing body parts, recover their normal appearance, and enhance their aesthetic beauty owing to the development of cosmetic implants. The cosmetic implants market has witnessed several acquisitions & mergers in recent years. For instance, in February 2016, DENTSPLY International Inc. and Sirona Dental Systems, Inc. merged together to form DENTSPLY Sirona Inc. to provide a strong and wide range of professional dental products and technologies to customers across 120 countries globally. Based on the applications segment, it is diversified into facial, breasts, body, neck, and others. The facial implants segment is the fastest-growing segment due to the growing demand for chin and cheek plastic surgeries. They are available in a wide range of sizes and styles and restore contour and proportion to your face. Along with this, the increasing prevalence of breast cancer has increased the demand for breast augmentation and breast lift procedures.Scope of the report: Inquire before Buying
Global Cosmetics Surgery Products Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 43.60 Bn. Forecast Period 2023 to 2029 CAGR: 4.5% Market Size in 2029: US $ 59.34 Bn. Segments Covered: by Types Injectables Implants Equipments Others by End User Hospitals Ambulatory Surgical Centers Clinics by Application Facial Breast Body Neck Cosmetic Surgery Products Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, Turkey, Russia and Rest of Europe) Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina, Columbia and Rest of South America)Cosmetic Surgery Products Market, Key Players are
1. Allergan 2. Mentor Corporation 3. Candela Corp 4. Cutera Inc 5. Lumenis Ltd. 6. Palomar Medical 7. Iridex Corp 8. Solta Medical 9. DermaMed Pharmaceutical Inc 10. Medtronic plc 11. Johnson & Johnson Services Inc. 12. Syneron Medical Ltd. 13. Cynosure Inc. 14. Alma Lasers, Ltd 15. Genesis Biosystems 16. Merz Aesthetics 17. Sanofi S.A. 18. Smith & Nephew plc 19. DENTSPLY Sirona plc. Frequently Asked Questions: 1] What segments are covered in Global Cosmetic Surgery Products Market report? Ans. The segments covered in Market report are based on Product, Type, and End-Use. 2] Which region is expected to hold the highest share in the Global Cosmetic Surgery Products Market? Ans. North America is expected to hold the highest share in the Burn Ointment Market. 3] Which segment holds the largest market share in the Global Cosmetic Surgery Products Market by 2029? Ans. Topical Antibiotics segment hold the largest market share in the market by 2029. 4] What is the market size of the Global Cosmetic Surgery Products Market by 2029? Ans. The market size of the market is expected to reach US $59.34 Bn. by 2029. 5] What was the market size of the Global Cosmetic Surgery Products Market in 2022? Ans. The market size of the market was worth US $43.60 Bn. in 2022.
Global Cosmetic Surgery Products Market
1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Market Size, By Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Cosmetic Surgery Products Market Analysis and Forecast 6.1. Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Cosmetic Surgery Products Market Analysis and Forecast, By Types 7.1. Introduction and Definition 7.2. Key Findings 7.3. Market Value Share Analysis, By Types 7.4. Market Size (US$ Mn) Forecast, By Types 7.5. Market Analysis, By Types 7.6. Market Attractiveness Analysis, By Types 8. Global Cosmetic Surgery Products Market Analysis and Forecast, By Application 8.1. Introduction and Definition 8.2. Key Findings 8.3. Market Value Share Analysis, By Application 8.4. Market Size (US$ Mn) Forecast, By Application 8.5. Market Analysis, By Application 8.6. Market Attractiveness Analysis, By Application 9. Global Cosmetic Surgery Products Market Analysis and Forecast By End-users 9.1. Introduction and Definition 9.2. Key Findings 9.3. Market Value Share Analysis, By End-users 9.4. Market Size (US$ Mn) Forecast, By End-users 9.5. Market Analysis, By End-users 9.6. Market Attractiveness Analysis, By End-users 10. Global Cosmetic Surgery Products Market Analysis, By Region 10.1. Market Value Share Analysis, By Region 10.2. Market Size (US$ Mn) Forecast, By Region 10.3. Market Attractiveness Analysis, By Region 11. North America Cosmetic Surgery Products Market Analysis 11.1. Key Findings 11.2. North America Market Overview 11.3. North America Market Value Share Analysis, By Types 11.4. North America Market Forecast, By Types 11.4.1. Injectables 11.4.2. Implants 11.4.3. Equipment 11.4.4. Others 11.5. North America Market Value Share Analysis, By Application 11.6. North America Market Forecast, By Application 11.6.1. Facial 11.6.2. Breast 11.6.3. Body 11.6.4. Neck 11.6.5. Others 11.7. North America Market Value Share Analysis, By End-users 11.8. North America Market Forecast, By End-users 11.8.1. Hospitals 11.8.2. Ambulatory Surgical Centers 11.8.3. Clinics 11.9. North America Market Value Share Analysis, By Country 11.10. North America Market Forecast, By Country 11.10.1. U.S. 11.10.2. Canada 11.10.3. Mexico 11.11. North America Market Analysis, By Country 11.12. U.S. Market Forecast, By Types 11.12.1. Injectables 11.12.2. Implants 11.12.3. Equipment 11.12.4. Others 11.13. U.S. Market Forecast, By Application 11.13.1. Facial 11.13.2. Breast 11.13.3. Body 11.13.4. Neck 11.13.5. Others 11.14. U.S. Market Forecast, By End-users 11.14.1. Hospitals 11.14.2. Ambulatory Surgical Centers 11.14.3. Clinics 11.15. Canada Market Forecast, By Types 11.15.1. Injectables 11.15.2. Implants 11.15.3. Equipment 11.15.4. Others 11.16. Canada Market Forecast, By Application 11.16.1. Facial 11.16.2. Breast 11.16.3. Body 11.16.4. Neck 11.16.5. Others 11.17. Canada Market Forecast, By End-users 11.17.1. Hospitals 11.17.2. Ambulatory Surgical Centers 11.17.3. Clinics 11.18. Mexico Market Forecast, By Types 11.18.1. Injectables 11.18.2. Implants 11.18.3. Equipment 11.18.4. Others 11.19. Mexico Market Forecast, By Application 11.19.1. Facial 11.19.2. Breast 11.19.3. Body 11.19.4. Neck 11.19.5. Others 11.20. Mexico Market Forecast, By End-users 11.20.1. Hospitals 11.20.2. Ambulatory Surgical Centers 11.20.3. Clinics 11.21. North America Market Attractiveness Analysis 11.21.1. By Types 11.21.2. By Application 11.21.3. By End-users 11.22. PEST Analysis 11.23. Key Trends 11.24. Key Developments 12. Europe Cosmetic Surgery Products Market Analysis 12.1. Key Findings 12.2. Europe Market Overview 12.3. Europe Market Value Share Analysis, By Types 12.4. Europe Market Forecast, By Types 12.4.1. Injectables 12.4.2. Implants 12.4.3. Equipment 12.4.4. Others 12.5. Europe Market Value Share Analysis, By Application 12.6. Europe Market Forecast, By Application 12.6.1. Facial 12.6.2. Breast 12.6.3. Body 12.6.4. Neck 12.6.5. Others 12.7. Europe Market Value Share Analysis, By End-users 12.8. Europe Market Forecast, By End-users 12.8.1. Hospitals 12.8.2. Ambulatory Surgical Centers 12.8.3. Clinics 12.9. Europe Market Value Share Analysis, By Country 12.10. Europe Market Forecast, By Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Sweden 12.10.7. CIS countries 12.10.8. Rest of Europe 12.11. Germany Market Forecast, By Types 12.11.1. Injectables 12.11.2. Implants 12.11.3. Equipment 12.11.4. Others 12.12. Germany Market Forecast, By Application 12.12.1. Facial 12.12.2. Breast 12.12.3. Body 12.12.4. Neck 12.12.5. Others 12.13. Germany Market Forecast, By End-users 12.13.1. Hospitals 12.13.2. Ambulatory Surgical Centers 12.13.3. Clinics 12.14. U.K. Market Forecast, By Types 12.14.1. Injectables 12.14.2. Implants 12.14.3. Equipment 12.14.4. Others 12.15. U.K. Market Forecast, By Application 12.15.1. Facial 12.15.2. Breast 12.15.3. Body 12.15.4. Neck 12.15.5. Others 12.16. U.K. Market Forecast, By End-users 12.16.1. Hospitals 12.16.2. Ambulatory Surgical Centers 12.16.3. Clinics 12.17. France Market Forecast, By Types 12.17.1. Injectables 12.17.2. Implants 12.17.3. Equipment 12.17.4. Others 12.18. France Market Forecast, By Application 12.18.1. Facial 12.18.2. Breast 12.18.3. Body 12.18.4. Neck 12.18.5. Others 12.19. France Market Forecast, By End-users 12.19.1. Hospitals 12.19.2. Ambulatory Surgical Centers 12.19.3. Clinics 12.20. Italy Market Forecast, By Types 12.20.1. Injectables 12.20.2. Implants 12.20.3. Equipment 12.20.4. Others 12.21. Italy Market Forecast, By Application 12.21.1. Facial 12.21.2. Breast 12.21.3. Body 12.21.4. Neck 12.21.5. Others 12.22. Italy Market Forecast, By End-users 12.22.1. Hospitals 12.22.2. Ambulatory Surgical Centers 12.22.3. Clinics 12.23. Spain Market Forecast, By Types 12.23.1. Injectables 12.23.2. Implants 12.23.3. Equipment 12.23.4. Others 12.24. Spain Market Forecast, By Application 12.24.1. Facial 12.24.2. Breast 12.24.3. Body 12.24.4. Neck 12.24.5. Others 12.25. Spain Market Forecast, By End-users 12.25.1. Hospitals 12.25.2. Ambulatory Surgical Centers 12.25.3. Clinics 12.26. Sweden Market Forecast, By Types 12.26.1. Injectables 12.26.2. Implants 12.26.3. Equipment 12.26.4. Others 12.27. Sweden Market Forecast, By Application 12.27.1. Facial 12.27.2. Breast 12.27.3. Body 12.27.4. Neck 12.27.5. Others 12.28. Sweden Market Forecast, By End-users 12.28.1. Hospitals 12.28.2. Ambulatory Surgical Centers 12.28.3. Clinics 12.29. CIS countries Market Forecast, By Types 12.29.1. Injectables 12.29.2. Implants 12.29.3. Equipment 12.29.4. Others 12.30. CIS countries Market Forecast, By Application 12.30.1. Facial 12.30.2. Breast 12.30.3. Body 12.30.4. Neck 12.30.5. Others 12.31. CIS countries Market Forecast, By End-users 12.31.1. Hospitals 12.31.2. Ambulatory Surgical Centers 12.31.3. Clinics 12.32. Rest of Europe Market Forecast, By Types 12.32.1. Injectables 12.32.2. Implants 12.32.3. Equipment 12.32.4. Others 12.33. Rest of Europe Market Forecast, By Application 12.33.1. Facial 12.33.2. Breast 12.33.3. Body 12.33.4. Neck 12.33.5. Others 12.34. Rest of Europe Market Forecast, By End-users 12.34.1. Hospitals 12.34.2. Ambulatory Surgical Centers 12.34.3. Clinics 12.35. Europe Market Attractiveness Analysis 12.35.1. By Application 12.35.2. By Types 12.35.3. By End-users 12.36. PEST Analysis 12.37. Key Trends 12.38. Key Developments 13. Asia Pacific Cosmetic Surgery Products Market Analysis 13.1. Key Findings 13.2. Asia Pacific Market Overview 13.3. Asia Pacific Market Value Share Analysis, By Types 13.4. Asia Pacific Market Forecast, By Types 13.4.1. Injectables 13.4.2. Implants 13.4.3. Equipment 13.4.4. Others 13.5. Asia Pacific Market Value Share Analysis, By Application 13.6. Asia Pacific Market Forecast, By Application 13.6.1. Facial 13.6.2. Breast 13.6.3. Body 13.6.4. Neck 13.6.5. Others 13.7. Asia Pacific Market Value Share Analysis, By End-users 13.8. Asia Pacific Market Forecast, By End-users 13.8.1. Hospitals 13.8.2. Ambulatory Surgical Centers 13.8.3. Clinics 13.9. Asia Pacific Market Value Share Analysis, By Country 13.10. Asia Pacific Market Forecast, By Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. South Korea 13.10.5. Australia 13.10.6. ASEAN 13.10.7. Rest of Asia Pacific 13.11. Asia Pacific Market Analysis, By Country 13.12. China Market Forecast, By Types 13.12.1. Injectables 13.12.2. Implants 13.12.3. Equipment 13.12.4. Others 13.13. China Market Forecast, By Application 13.13.1. Facial 13.13.2. Breast 13.13.3. Body 13.13.4. Neck 13.13.5. Others 13.14. China Market Forecast, By End-users 13.14.1. Hospitals 13.14.2. Ambulatory Surgical Centers 13.14.3. Clinics 13.15. India Market Forecast, By Types 13.15.1. Injectables 13.15.2. Implants 13.15.3. Equipment 13.15.4. Others 13.16. India Market Forecast, By Application 13.16.1. Facial 13.16.2. Breast 13.16.3. Body 13.16.4. Neck 13.16.5. Others 13.17. India Market Forecast, By End-users 13.17.1. Hospitals 13.17.2. Ambulatory Surgical Centers 13.17.3. Clinics 13.18. Japan Market Forecast, By Types 13.18.1. Injectables 13.18.2. Implants 13.18.3. Equipment 13.18.4. Others 13.19. Japan Market Forecast, By Application 13.19.1. Facial 13.19.2. Breast 13.19.3. Body 13.19.4. Neck 13.19.5. Others 13.20. Japan Market Forecast, By End-users 13.20.1. Hospitals 13.20.2. Ambulatory Surgical Centers 13.20.3. Clinics 13.21. South Korea Market Forecast, By Types 13.21.1. Injectables 13.21.2. Implants 13.21.3. Equipment 13.21.4. Others 13.22. South Korea Market Forecast, By Application 13.22.1. Facial 13.22.2. Breast 13.22.3. Body 13.22.4. Neck 13.22.5. Others 13.23. South Korea Market Forecast, By End-users 13.23.1. Hospitals 13.23.2. Ambulatory Surgical Centers 13.23.3. Clinics 13.24. Australia Market Forecast, By Types 13.24.1. Injectables 13.24.2. Implants 13.24.3. Equipment 13.24.4. Others 13.25. Australia Market Forecast, By Application 13.25.1. Facial 13.25.2. Breast 13.25.3. Body 13.25.4. Neck 13.25.5. Others 13.26. Australia Market Forecast, By End-users 13.26.1. Hospitals 13.26.2. Ambulatory Surgical Centers 13.26.3. Clinics 13.27. ASEAN Market Forecast, By Types 13.27.1. Injectables 13.27.2. Implants 13.27.3. Equipment 13.27.4. Others 13.28. ASEAN Market Forecast, By Application 13.28.1. Facial 13.28.2. Breast 13.28.3. Body 13.28.4. Neck 13.28.5. Others 13.29. ASEAN Market Forecast, By End-users 13.29.1. Hospitals 13.29.2. Ambulatory Surgical Centers 13.29.3. Clinics 13.30. Rest of Asia Pacific Market Forecast, By Types 13.30.1. Injectables 13.30.2. Implants 13.30.3. Equipment 13.30.4. Others 13.31. Rest of Asia Pacific Market Forecast, By Application 13.31.1. Facial 13.31.2. Breast 13.31.3. Body 13.31.4. Neck 13.31.5. Others 13.32. Rest of Asia Pacific Market Forecast, By End-users 13.32.1. Hospitals 13.32.2. Ambulatory Surgical Centers 13.32.3. Clinics 13.33. Asia Pacific Market Attractiveness Analysis 13.33.1. By Types 13.33.2. By Application 13.33.3. By End-users 13.34. PEST Analysis 13.35. Key Trends 13.36. Key Developments 14. Middle East & Africa Cosmetic Surgery Products Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Market Overview 14.3. Middle East & Africa Market Value Share Analysis, By Types 14.4. Middle East & Africa Market Forecast, By Types 14.4.1. Injectables 14.4.2. Implants 14.4.3. Equipment 14.4.4. Others 14.5. Middle East & Africa Market Value Share Analysis, By Application 14.6. Middle East & Africa Market Forecast, By Application 14.6.1. Facial 14.6.2. Breast 14.6.3. Body 14.6.4. Neck 14.6.5. Others 14.7. Middle East & Africa Market Value Share Analysis, By End-users 14.8. Middle East & Africa Market Forecast, By End-users 14.8.1. Hospitals 14.8.2. Ambulatory Surgical Centers 14.8.3. Clinics 14.9. Middle East & Africa Market Value Share Analysis, By Country 14.10. Middle East & Africa Market Forecast, By Country 14.10.1. GCC Countries 14.10.2. South Africa 14.10.3. Nigeria 14.10.4. Egypt 14.10.5. Rest of Middle East & Africa 14.11. Middle East & Africa Market Analysis, By Country 14.12. GCC Countries Market Forecast, By Types 14.12.1. Injectables 14.12.2. Implants 14.12.3. Equipment 14.12.4. Others 14.13. GCC Countries Market Forecast, By Application 14.13.1. Facial 14.13.2. Breast 14.13.3. Body 14.13.4. Neck 14.13.5. Others 14.14. GCC Countries Market Forecast, By End-users 14.14.1. Hospitals 14.14.2. Ambulatory Surgical Centers 14.14.3. Clinics 14.15. South Africa Market Forecast, By Types 14.15.1. Injectables 14.15.2. Implants 14.15.3. Equipment 14.15.4. Others 14.16. South Africa Market Forecast, By Application 14.16.1. Facial 14.16.2. Breast 14.16.3. Body 14.16.4. Neck 14.16.5. Others 14.17. South Africa Market Forecast, By End-users 14.17.1. Hospitals 14.17.2. Ambulatory Surgical Centers 14.17.3. Clinics 14.18. Nigeria Market Forecast, By Types 14.18.1. Injectables 14.18.2. Implants 14.18.3. Equipment 14.18.4. Others 14.19. Nigeria Market Forecast, By Application 14.19.1. Facial 14.19.2. Breast 14.19.3. Body 14.19.4. Neck 14.19.5. Others 14.20. Nigeria Market Forecast, By End-users 14.20.1. Hospitals 14.20.2. Ambulatory Surgical Centers 14.20.3. Clinics 14.21. Egypt Market Forecast, By Types 14.21.1. Injectables 14.21.2. Implants 14.21.3. Equipment 14.21.4. Others 14.22. Egypt Market Forecast, By Application 14.22.1. Facial 14.22.2. Breast 14.22.3. Body 14.22.4. Neck 14.22.5. Others 14.23. Egypt Market Forecast, By End-users 14.23.1. Hospitals 14.23.2. Ambulatory Surgical Centers 14.23.3. Clinics 14.24. Rest of Middle East & Africa Market Forecast, By Types 14.24.1. Injectables 14.24.2. Implants 14.24.3. Equipment 14.24.4. Others 14.25. Rest of Middle East & Africa Market Forecast, By Application 14.25.1. Facial 14.25.2. Breast 14.25.3. Body 14.25.4. Neck 14.25.5. Others 14.26. Rest of Middle East & Africa Market Forecast, By End-users 14.26.1. Hospitals 14.26.2. Ambulatory Surgical Centers 14.26.3. Clinics 14.27. Middle East & Africa Market Attractiveness Analysis 14.27.1. By Types 14.27.2. By Application 14.27.3. By End-users 14.28. PEST Analysis 14.29. Key Trends 14.30. Key Developments 15. South America Cosmetic Surgery Products Market Analysis 15.1. Key Findings 15.2. South America Market Overview 15.3. South America Market Value Share Analysis, By Types 15.4. South America Market Forecast, By Types 15.4.1. Injectables 15.4.2. Implants 15.4.3. Equipment 15.4.4. Others 15.5. South America Market Value Share Analysis, By Application 15.6. South America Market Forecast, By Application 15.6.1. Facial 15.6.2. Breast 15.6.3. Body 15.6.4. Neck 15.6.5. Others 15.7. South America Market Value Share Analysis, By End-users 15.8. South America Market Forecast, By End-users 15.8.1. Hospitals 15.8.2. Ambulatory Surgical Centers 15.8.3. Clinics 15.9. South America Market Value Share Analysis, By Country 15.10. South America Market Forecast, By Country 15.10.1. Brazil 15.10.2. Colombia 15.10.3. Argentina 15.10.4. Rest of South America 15.11. South America Market Analysis, By Country 15.12. Brazil Market Forecast, By Types 15.12.1. Injectables 15.12.2. Implants 15.12.3. Equipment 15.12.4. Others 15.13. Brazil Market Forecast, By Application 15.13.1. Facial 15.13.2. Breast 15.13.3. Body 15.13.4. Neck 15.13.5. Others 15.14. Brazil Market Forecast, By End-users 15.14.1. Hospitals 15.14.2. Ambulatory Surgical Centers 15.14.3. Clinics 15.15. Colombia Market Forecast, By Types 15.15.1. Injectables 15.15.2. Implants 15.15.3. Equipment 15.15.4. Others 15.16. Colombia Market Forecast, By Application 15.16.1. Facial 15.16.2. Breast 15.16.3. Body 15.16.4. Neck 15.16.5. Others 15.17. Colombia Market Forecast, By End-users 15.17.1. Hospitals 15.17.2. Ambulatory Surgical Centers 15.17.3. Clinics 15.18. Argentina Market Forecast, By Types 15.18.1. Injectables 15.18.2. Implants 15.18.3. Equipment 15.18.4. Others 15.19. Argentina Market Forecast, By Application 15.19.1. Facial 15.19.2. Breast 15.19.3. Body 15.19.4. Neck 15.19.5. Others 15.20. Argentina Market Forecast, By End-users 15.20.1. Hospitals 15.20.2. Ambulatory Surgical Centers 15.20.3. Clinics 15.21. Rest of South America Market Forecast, By Types 15.21.1. Injectables 15.21.2. Implants 15.21.3. Equipment 15.21.4. Others 15.22. Rest of South America Market Forecast, By Application 15.22.1. Facial 15.22.2. Breast 15.22.3. Body 15.22.4. Neck 15.22.5. Others 15.23. Rest of South America Market Forecast, By End-users 15.23.1. Hospitals 15.23.2. Ambulatory Surgical Centers 15.23.3. Clinics 15.24. South America Market Attractiveness Analysis 15.24.1. By Types 15.24.2. By Application 15.24.3. By End-users 15.25. PEST Analysis 15.26. Key Trends 15.27. Key Developments 16. Company Profiles 16.1. Market Share Analysis, By Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players By price, presence, market share, Component, and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A By Regions, Investment and Component 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Allergan 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Development Footprint 16.3.2. Mentor Corporation 16.3.3. Candela Corp 16.3.4. Cutera Inc 16.3.5. Lumenis Ltd. 16.3.6. Palomar Medical 16.3.7. Iridex Corp 16.3.8. Solta Medical 16.3.9. DermaMed Pharmaceutical Inc 16.3.10. Medtronic plc 16.3.11. Johnson & Johnson Services Inc. 16.3.12. Syneron Medical Ltd. 16.3.13. Cynosure Inc. 16.3.14. Alma Lasers, Ltd 16.3.15. Genesis Biosystems 16.3.16. Merz Aesthetics 16.3.17. Sanofi S.A. 16.3.18. Smith & Nephew plc 16.3.19. DENTSPLY Sirona 17. Primary key Insights